FibroGen, Inc.FGENNASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
-20.18%
↓ 113% below average
Average (39q)
151.00%
Historical baseline
Range
High:4542.59%
Low:-366.02%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -20.18% |
| Q2 2025 | -50.78% |
| Q1 2025 | 102.22% |
| Q4 2024 | -366.02% |
| Q3 2024 | 4542.59% |
| Q2 2024 | -96.07% |
| Q1 2024 | -6.54% |
| Q4 2023 | -32.38% |
| Q3 2023 | -9.44% |
| Q2 2023 | 22.56% |
| Q1 2023 | 5.22% |
| Q4 2022 | 118.41% |
| Q3 2022 | -47.21% |
| Q2 2022 | -51.00% |
| Q1 2022 | 267.69% |
| Q4 2021 | -89.39% |
| Q3 2021 | 540.18% |
| Q2 2021 | -36.60% |
| Q1 2021 | -40.88% |
| Q4 2020 | 47.62% |
| Q3 2020 | 2.67% |
| Q2 2020 | 75.76% |
| Q1 2020 | 206.01% |
| Q4 2019 | -75.96% |
| Q3 2019 | -82.68% |
| Q2 2019 | 702.77% |
| Q1 2019 | -77.92% |
| Q4 2018 | 272.25% |
| Q3 2018 | -33.96% |
| Q2 2018 | 37.67% |
| Q1 2018 | -24.90% |
| Q4 2017 | 55.87% |
| Q3 2017 | -5.95% |
| Q2 2017 | 7.83% |
| Q1 2017 | -15.73% |
| Q4 2016 | 6.01% |
| Q3 2016 | -66.28% |
| Q2 2016 | 215.68% |
| Q1 2016 | 15.71% |
| Q4 2015 | 25.10% |